Date: Wednesday, May 15, 2024 - Friday, May 17, 2024
Where:: Hilton Washington D.C. National Mall the Wharf
The Joint ASTCT + EBMT Basic and Translational Scientific Meeting is a 2.5-day conference focused on cutting-edge basic and translational biology in the field. The meeting will focus on fundamental themes and novel technologies with an emphasis on unpublished and innovative science. Attendance to the meeting will be limited to 120 attendees with afternoon breaks to allow for informal networking opportunities between junior and senior attendees. The meeting will host two days of poster sessions and a best oral abstract session.
|Trainee & Junior Faculty*
|Allied Health Professionals
*Junior attendees are defined as post doctoral fellows, current fellows, and junior faculty within the first three years of appointment.
Registration to this event is limited to a maximum of 100 total attendees. We are unable to accept additional registrants once the registration capacity has been met.
This conference is only for physicians and scientists who are currently practicing in the field of transplantation and cellular therapy and sponsoring companies. Please contact Angie Dahl (firstname.lastname@example.org) if you are interested in participating as a sponsor.
ASTCT and EBMT invite you to submit an abstract to present at the Joint Scientific Meeting. This opportunity allows attendees to share their research with an international audience and experts in the field. We encourage junior and senior members of the hematopoietic stem cell therapy and cellular therapies field to submit an abstract. The abstract submission window will close on Friday, March 1 at 5:00 p.m. CT.
The program includes a dedicated poster viewing hour for attendees to share their research and network. Five abstracts will be selected to present as an oral throughout the meeting. Abstract topics can include, but are not limited to, immune metabolism, GVHD, stem cell biology, cell engineering, and anti-leukemic strategies.
ADD TO CALENDAR
View All Events